ORKA - Oruka Therapeutics, Inc.
44.48
-0.980 -2.203%
Share volume: 885,714
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$45.46
-0.98
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 08-01-2024 | 11-13-2024 | 05-14-2025 | 08-11-2025 | 11-12-2025 | 03-12-2026 | |
| Cash flow financing | 0.000 | 14.000 K | 0.000 | 0.000 | 109.000 K | 169.908 M | 298.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -1.528 M | 0.000 | 0.000 | 21.997 M | -18.176 M | 25.857 M | -44.318 M | |
| Net income | -2.009 M | -2.678 M | -27.293 M | -20.999 M | -24.574 M | -30.277 M | -29.583 M | |
| Depreciation | 3.000 K | 3.000 K | 0.000 | 16.000 K | 19.000 K | 20.000 K | 28.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 42.866 M | 4.860 M | -122.449 M | -22.022 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 63.000 K | |
| Cash Change | -1.528 M | -2.620 M | 0.000 | 21.997 M | -18.176 M | 25.857 M | -44.318 M |